Business · 21/12/2004Updated: 10/17/2026 · 1 min read
Meeting of the Advisory Committee on Blood Safety and Availability
Summary
The Advisory Committee on Blood Safety and Availability will review progress, solicit comments, and discuss updates on blood safety and rare blood disorders, including bacterial contamination and infectious agent strategies.
Original source language: Federal Register — Health and Human ServicesOpen original release →